Novo Nordisk Total Current Liabilities 2010-2024 | NVO

Novo Nordisk total current liabilities for the quarter ending June 30, 2024 were $27.115B, a 18.5% increase year-over-year.

  • Novo Nordisk total current liabilities for 2023 were $24.634B, a 43.85% increase from 2022.
  • Novo Nordisk total current liabilities for 2022 were $17.125B, a 8.16% increase from 2021.
  • Novo Nordisk total current liabilities for 2021 were $15.833B, a 47.07% increase from 2020.

Novo Nordisk Total Current Liabilities 2010-2024 | NVO

  • Novo Nordisk total current liabilities for 2023 were $24.634B, a 43.85% increase from 2022.
  • Novo Nordisk total current liabilities for 2022 were $17.125B, a 8.16% increase from 2021.
  • Novo Nordisk total current liabilities for 2021 were $15.833B, a 47.07% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$495.1B
Johnson & Johnson (JNJ)$450.1B
Merck (MRK)$270B
AbbVie (ABBV)$264.1B
AstraZeneca (AZN)$218.5B
Novartis AG (NVS)$218.4B
Pfizer (PFE)$201.2B
Sanofi (SNY)$133B
Innoviva (INVA)$953M